comparemela.com

Latest Breaking News On - Pimera therapeutics - Page 1 : comparemela.com

Pimera Therapeutics Announces Oral Presentation on PMR-116 at the American Association for Cancer Research (AACR) Annual Meeting 2022

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

United statesAmy conradOrleans convention centerAmerican association for cancer researchPimera therapeutics incPimera therapeuticsAmerican associationCancer researchAnnual meetingNew orleansGreat hallNew orleans conventionInvestor contact

Pimera Therapeutics Announces Oral Presentation on PMR-116 at the American Association for Cancer Research (AACR) Annual Meeting 2022

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

United statesAmy conradOrleans convention centerAmerican association for cancer researchPimera therapeutics incPimera therapeuticsAmerican associationCancer researchAnnual meetingNew orleansGreat hallNew orleans conventionInvestor contact

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

Mustapha haddachAmy conradLuc furicRoss hannanAustralian national universityDepartment of defenseDean research biomedicalCancer researchProstate cancer research programDepartment of cancer biologyPimera therapeutics incPimera therapeuticsTranslational prostate cancer researchPeter maccallum cancer centreProfessor ross hannanCentenary chair

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

Mustapha haddachAmy conradLuc furicRoss hannanAustralian national universityDepartment of defenseDean research biomedicalCancer researchProstate cancer research programDepartment of cancer biologyPimera therapeutics incPimera therapeuticsTranslational prostate cancer researchPeter maccallum cancer centreProfessor ross hannanCentenary chair

vimarsana © 2020. All Rights Reserved.